Format

Send to

Choose Destination
Angiology. 2017 Jan;68(1):67-73. Epub 2016 Mar 15.

Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions.

Author information

1
Department of cardiology, Saiseikai Central Hospital, Minato-ku, Tokyo, Japan k-y.suzuki@nifty.com.
2
Cardiovascular Center, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
3
Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan.
4
Cardiovascular Division, Kansai Rosai Hospital, Nishinomiya, Hyogo, Japan.
5
Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
6
Kikuna Memorial Hospital, Yokohama, Kanagawa, Japan.
7
Saiseikai Yokohama-City Eastern Hospital, Yokohama, Kanagawa, Japan.
8
Tokeidai Memorial Hospital, Sapporo, Hokkaido, Japan.
9
Nagoya Kyoritsu Hospital, Nagoya, Aichi, Japan.
10
Kyoto University Hospital, Kyoto, Kyoto, Japan.
11
Sakakibara Heart Institute, Fuchu, Tokyo, Japan.
12
Shin-Koga Hospital, Kurume, Fukuoka, Japan.
13
Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan.
14
Juntendo University Nerima Hospital, Nerima, Tokyo, Japan.
15
Japanese Red Cross Fukuoka Hospital, Minami-ku, Fukuoka, Japan.
16
Kanazawa Medical University Hospital, Kahoku, Ishikawa, Japan.
17
Shinshu University Hospital, Matsumoto, Nagano, Japan.
18
Tokai University Hospital, Isehara, Kanagawa, Japan.
19
Yamagata University Hospital, Iidanishi, Yamagata, Japan.

Abstract

BACKGROUND:

Although there is increasing evidence of the effectiveness of endovascular therapy for complex aortoiliac (AI) occlusive disease, it is not universally applied to TASC D lesions.

METHODS:

A total of 2096 patients, 2601 limbs with AI occlusive disease, were enrolled. The lesions were categorized as TASC D (395) or TASC A-C (2206), and we compared baseline data, procedure, and follow-up result between the 2 groups.

RESULTS:

The success rate of the procedure was significantly lower in the TASC D group (91.6% vs 99.3%, P < .01), and more procedure complications occurred in the TASC D group (11.1% vs 5.2%, P < .01). The results of a 5-year follow-up revealed no significant difference in primary patency (77.9% vs 77.1%, P = .17) and major adverse cardiovascular and limb events (MACLE; 30.5% vs 33.4%, P = .42) between the 2 groups. A multivariate analysis revealed complications and critical limb ischemia are independent predictors of MACLE in the TASC D group.

CONCLUSION:

The success rate of the procedure was lower in the TASC D group. Complications were more frequent in the TASC D group, and they were related to MACLE.

KEYWORDS:

TASC D; aortoiliac; endovascular therapy

PMID:
26980775
DOI:
10.1177/0003319716638005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center